Printer Friendly

Articles from M2 Pharma (November 14, 2019)

1-10 out of 10 article(s)
Title Author Type Words
First Light Diagnostics adds new member to international clinical advisory board. 193
LEO Pharma Exercises Option with HitGen to License Compounds for Development of Novel Class of Drugs in Dermatology. Drug overview 414
Lupin to sell complete Kyowa Pharmaceutical share to Unison. 221
MeMed receives EUR2.5m in non-dilutive funding from the European Innovation Council. 277
Merck's ERVEBO Ebola Zaire Vaccine Granted Conditional Approval in the European Union. 526
Mylan and Upjohn merge to form Viatris. 184
NEC and Vaximm Forge Clinical Trial Collaboration. 224
Newly Published Research Demonstrates Ability of Hologic's Assay to Detect Mycoplasma Genitalium, "the Silent Epidemic". Clinical report 500
Promethera Biosciences, Medipal Enter Alliance Pact. 342
US FDA grants Breakthrough Therapy Designation to X4 Pharmaceuticals' mavorixafor. 235

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters